US Pharma MarketingThe post Study finds metabolic biomarker signature to assist with early HNSCC detection appeared first on Clinical Trials Arena.
Study finds metabolic biomarker signature to assist with early HNSCC detection
According to the WHO, HNSCC ranks as the seventh most common cancer and is the sixth leading cause of cancer-related mortality worldwide. The post Study finds metabolic biomarker signature to assist with early HNSCC detection appeared first on Clinical Trials Arena .
According to the WHO, HNSCC ranks as the seventh most common cancer and is the sixth leading cause of cancer-related mortality worldwide.
Source: Clinical Trials Arena